comparemela.com

Latest Breaking News On - Systems united statesa - Page 8 : comparemela.com

Organic Expansion To Bring A Major Breakthrough In The Endoscopic Submucosal Dissection Market – KSU

Organic Expansion To Bring A Major Breakthrough In The Endoscopic Submucosal Dissection Market atulpmrMay 24, 2021 Like all the other verticals, the healthcare vertical is poised to witness an amalgamation of collaborations and networks as a result of the culture of belonging and inclusion being the new DNA therein. Also, remote work arrangements will be simplified with shared services, cloud technologies, and AI is in place. The Endoscopic Submucosal Dissection Market is meant to capture these happenings and give insights regarding the same. Endoscopic Submucosal Dissection (ESD) has witnessed slow adoption in Western countries in the past. This is due to the continued referral of patients for surgery or Endoscopic Mucosal Resection (EMR) procedures.

Fujifilm Showcases Comprehensive Portfolio of Enterprise Imaging Solutions at the Virtual SIIM 2021 Conference

FUJIFILM Medical Systems U.S.A., Inc. announced it will showcase its portfolio of Synapse® Enterprise Imaging solutions at the 2021 Society for Imaging Informatics in Medicine (SIIM) Conference taking place May 24- 27.

FUJIFILM Medical Systems U S A , Inc and Helio Health Collaborate to Advance Blood-based Screening Methods for Early-Stage Liver Cancer

(PRNewsfoto/Fujifilm) LEXINGTON, Mass. and IRVINE, Calif., May 12, 2021 /PRNewswire/  FUJIFILM Medical Systems U.S.A., Inc., a leading provider of biomarkers to assess the risk for the development of hepatocellular carcinoma (HCC), and Helio Health, an AI-driven healthcare company developing early cancer detection tests, today announced their collaboration to provide a blood-based assay that can help with the earlier detection of liver cancer. Through this relationship, Helio Health’s DNA methylation and biomarker-based blood test technology, recognized as the HelioLiver Test, will leverage Fujifilm’s 510(k)-cleared µTASWako® i30 Immunological test system for liver cancer biomarkers. Liver cancer is the fastest growing and second deadliest cancer worldwide. According to the American Cancer Society, liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time. Studies show that early detection of liver cancer i

The Endoscopic Submucosal Dissection Market To Carve A Niche For Itself With Top Key-Players  Holding The Baton – KSU

US$ 200 Mn in  CAGR of  2019–2029). Key Takeaways of Endoscopic Submucosal Dissection Market Study ESD is predominantly used for early stomach cancer. This is because the procedure is easy and well-studied for stomach cancer as compared to other gastric cancers. Colorectal cancers are the most complex for ESD procedures, primarily due to the large size of lesions and anatomy of the colon. Specialty clinics are expected to gain traction with the rising adoption of ESD in the Western hemisphere. Endoscopic submucosal dissection knives hold nearly  1/3 market share in the endoscopic submucosal dissection market, followed by tissue retractors. The knives segment is expected to continue holding a relatively similar share through 

Dynamsoft Document Scan SDK Boosts Imaging Security and Builds Upon its Device Support

Dynamsoft Document Scan SDK Boosts Imaging Security and Builds Upon its Device Support Share Article The New SDK, Dynamic Web TWAIN v17, Has Improved its Encryption Algorithm for Cached Images and Adds 64-bit ARM and MIPS Processor Support to Support More Embedded Devices Dynamsoft Dynamic Web TWAIN Image Viewer The addition of support for 64-bit ARM and MIPS computing devices lets Dynamic Web TWAIN be used across even more devices. VANCOUVER, British Columbia (PRWEB) April 27, 2021 Dynamsoft™ has updated its document capture software development kit with a new algorithm to improve security for images being used under its hood. It has also added support for 64-bit ARM and MIPS based devices, which enables document scan and editing from more supported device platforms.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.